Related Experiment Video
Updated: Jun 14, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Changes in the Ca2+-activated K+ channels of the coronary artery during left ventricular hypertrophy
Nari Kim1, Joonyong Chung, Euiyong Kim
1Department of Physiology & Biophysics, College of Medicine, Inje University, Busanjin-Gu, Busan, Korea.
Insights
Left ventricular hypertrophy (LVH) impairs coronary smooth muscle cell (SMC) function by altering calcium-activated potassium (KCa) channels. These KCa channel changes reduce coronary reserve during LVH.
Area of Science:
- Cardiovascular Physiology
- Ion Channel Biology
- Smooth Muscle Cell Function
Background:
- Left ventricular hypertrophy (LVH) is associated with reduced coronary reserve.
- Impaired smooth muscle cell (SMC) function is a proposed mechanism for reduced coronary reserve in LVH.
- Alterations in Ca2+-activated K+ (KCa) channels in coronary SMCs have been hypothesized to contribute to this impairment.
Purpose of the Study:
- To investigate whether KCa channel properties are altered in coronary SMCs during LVH.
- To determine the functional consequences of these potential alterations on coronary artery function.
Main Methods:
- Patch-clamp electrophysiology to measure KCa channel currents in coronary SMCs from control and LVH models.
- Analysis of unitary current amplitude and open probability of KCa channels.
- Western blot analysis to assess KCa channel expression.
- Vascular contraction experiments to evaluate the role of KCa channels in coronary artery tone.
Main Results:
- Whole-cell KCa currents were reduced in LVH coronary SMCs compared to controls.
- Unitary current amplitude and open probability of KCa channels were significantly decreased in LVH.
- The concentration-response curve for intracellular calcium ([Ca2+]i) was shifted rightward, indicating reduced channel sensitivity to calcium.
- Inhibition of KCa channels by tetraethylammonium (TEA) was more pronounced in control cells than in LVH cells.
- Western blot showed no difference in KCa channel expression levels.
- LVH coronary arteries exhibited increased resting tension in response to high K+ and reduced responsiveness to TEA.
Conclusions:
- KCa channel function, not expression, is impaired in coronary SMCs during LVH.
- Reduced KCa channel activity contributes to altered coronary artery tone and reduced coronary reserve in LVH.
- These findings suggest a novel mechanism for impaired coronary vasodilation in LVH.
Abstract:
It has been suggested that impairment of smooth muscle cell (SMC) function by alterations in the Ca2+-activated K+ (KCa) channels accounts for the reduction in coronary reserve during left ventricular hypertrophy (LVH). However, this hypothesis has not been fully investigated. The main goal of this study was to assess whether the properties of KCa channels in coronary SMCs were altered during LVH. In patch-clamp experiments, the whole-cell currents of the KCa channels were reduced during LVH. The unitary current amplitude and open probability for the KCa channels were significantly reduced in LVH patches compared with control patches. The concentration-response curve of the KCa channel to [Ca2+]i was shifted to the right. Inhibition of the KCa channels by tetraethylammonium (TEA) was more pronounced in LVH cells than in control cells. Western blot analysis indicated no differences in KCa channel expression between the control and LVH coronary SM membranes. In contraction experiments, the effect of high K+ concentration on the resting tension of the LVH coronary artery was greater than on that of the control. The effect of TEA on the resting tension of the LVH coronary artery was reduced compared with the effect on the control. Our findings imply a novel mechanism for reduced coronary reserve during LVH.
Related Concept Videos
Antihypertensive Drugs: Action of Calcium Channel Blockers
Coronary Artery Disease II: Pathophysiology
Heart Failure II: Pathophysiology
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cellular Adaptation II: Hypertrophy

